1199,128: Multicenter, randomised, double-blind, Phase lll trial to investigate the efficacy and safetyof oral nintedanib plus docetaxel therapy compared to placebo plus docetaxel therapy in patients with stage lllB/IV or current, adenocarcinoma subtype

  • Willis, Maurice, (PI)

    Project: Other project

    StatusFinished
    Effective start/end date6/3/1512/1/17

    Funding

    • Boehringer Ingelheim Pharmaceuticals: $6,153.85